📧 Communication

This document is a printout of a May 29, 2013, Los Angeles Times interview with Alan Trounson, the president of the California Institute for Regenerative Medicine (CIRM). The article discusses the history of California's $3 billion funding for stem cell research (Proposition 71) and Trounson outlines current progress, including moving projects to clinical trials and banking 'induced pluripotent stem cells' (IPS) for studying complex diseases. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely part of a document production for a congressional investigation.